Schedule 13D ownership disclosure

Mirna Therapeutics, Inc.

Security class unavailable · CUSIP: 60470J103

Event date: 2015-10-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-15-000433
Form type
SC 13D
Filer
SYNLOGIC, INC.
CIK
CIK 1527599
Filed
Oct 14, 2015
Reporting period
Oct 06, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub